Scientists Develop Promising Blood Test to Detect Early Warning Signs of Ovarian Cancer

Researchers have identified a promising blood-based diagnostic technique that could help detect early biological changes associated with ovarian cancer, potentially improving preventive care for women at increased risk of developing the disease. The findings, published in the scientific journal Nature Medicine, represent an advancement in efforts to identify cancer before it reaches an invasive stage.

The study, led by Rajan Gogna of the Hoag Family Cancer Institute in California, focused on detecting serous tubal intraepithelial carcinoma (STIC), a microscopic precancerous condition that develops in the lining of the fallopian tubes. Such abnormalities are difficult to identify using conventional diagnostic methods.

Scientists discovered that women with STIC exhibited elevated blood levels of an RNA molecule known as Tu-Stroma. By measuring this molecular marker, researchers successfully identified the condition in 92.3% of affected women while correctly distinguishing 98.2% of healthy participants.

Among women with inherited genetic risk factors for ovarian cancer, the findings suggested that approximately 72% of positive test results would be accurate, while negative results could approach 100% accuracy under the study's modelled conditions.

The discovery could eventually assist women carrying cancer-associated genetic mutations, particularly those considering preventive surgery to remove their ovaries and fallopian tubes. A reliable blood test could provide additional biological information to support these complex medical decisions.

However, researchers emphasised that further clinical investigations are necessary to establish the test's effectiveness in broader populations.

Although the technique remains experimental, the findings suggest a potential shift towards identifying precancerous molecular changes rather than relying solely on detecting established tumours.

11-11-2026